FR3053339B1 - BIOMARKER FOR THE DIAGNOSIS OF CHRONIC INFLAMMATORY DISEASES OF THE INTESTINE - Google Patents

BIOMARKER FOR THE DIAGNOSIS OF CHRONIC INFLAMMATORY DISEASES OF THE INTESTINE Download PDF

Info

Publication number
FR3053339B1
FR3053339B1 FR1656344A FR1656344A FR3053339B1 FR 3053339 B1 FR3053339 B1 FR 3053339B1 FR 1656344 A FR1656344 A FR 1656344A FR 1656344 A FR1656344 A FR 1656344A FR 3053339 B1 FR3053339 B1 FR 3053339B1
Authority
FR
France
Prior art keywords
diagnosis
biomarker
chronic inflammatory
intestine
inflammatory diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1656344A
Other languages
French (fr)
Other versions
FR3053339A1 (en
Inventor
Iain K Pemberton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ip Res Consulting
Original Assignee
Ip Res Consulting
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ip Res Consulting filed Critical Ip Res Consulting
Priority to FR1656344A priority Critical patent/FR3053339B1/en
Publication of FR3053339A1 publication Critical patent/FR3053339A1/en
Application granted granted Critical
Publication of FR3053339B1 publication Critical patent/FR3053339B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205—Phosphotransferases in general
    • G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
    • G01N2333/91215—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases with a definite EC number (2.7.1.-)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne l'utilisation d'un biomarqueur pour le diagnostic d'une maladie inflammatoire chronique de l'intestin, une méthode de diagnostic, une méthode d'évaluation de l'efficacité d'un traitement, une méthode de dosage, ainsi que des kits et des substrats enzymatiques.The invention relates to the use of a biomarker for the diagnosis of chronic inflammatory bowel disease, a method of diagnosis, a method of evaluating the efficacy of a treatment, a method of assay, and so on. as kits and enzyme substrates.

FR1656344A 2016-07-01 2016-07-01 BIOMARKER FOR THE DIAGNOSIS OF CHRONIC INFLAMMATORY DISEASES OF THE INTESTINE Expired - Fee Related FR3053339B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1656344A FR3053339B1 (en) 2016-07-01 2016-07-01 BIOMARKER FOR THE DIAGNOSIS OF CHRONIC INFLAMMATORY DISEASES OF THE INTESTINE

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1656344 2016-07-01
FR1656344A FR3053339B1 (en) 2016-07-01 2016-07-01 BIOMARKER FOR THE DIAGNOSIS OF CHRONIC INFLAMMATORY DISEASES OF THE INTESTINE

Publications (2)

Publication Number Publication Date
FR3053339A1 FR3053339A1 (en) 2018-01-05
FR3053339B1 true FR3053339B1 (en) 2021-04-23

Family

ID=56943748

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1656344A Expired - Fee Related FR3053339B1 (en) 2016-07-01 2016-07-01 BIOMARKER FOR THE DIAGNOSIS OF CHRONIC INFLAMMATORY DISEASES OF THE INTESTINE

Country Status (1)

Country Link
FR (1) FR3053339B1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011299088B2 (en) * 2010-09-09 2015-12-24 Traxxsson, Llc Combination methods of diagnosing cancer in a patient
US20140315194A1 (en) * 2011-04-20 2014-10-23 Traxxsson, Llc Methods of diagnosing cancer in a patient
US20140113306A1 (en) * 2012-10-17 2014-04-24 Rutgers, The State University Of New Jersey Diagnostic and screening methods for inflammation

Also Published As

Publication number Publication date
FR3053339A1 (en) 2018-01-05

Similar Documents

Publication Publication Date Title
MX2025006655A (en) Methods for determining dpp3 and therapeutic methods
EP2539470A4 (en) METHODS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASES
TN2019000099A1 (en) ANTI-LAG-3 ANTIBODIES AND COMPOSITIONS
MA40755B1 (en) Compositions comprising bacterial strains
MA40754B1 (en) Compositions comprising bacterial strains
MA41060A (en) COMPOSITIONS INCLUDING BACTERIAL STRAINS
MA55434A (en) COMPOSITIONS COMPRISING BACTERIAL STRAINS
EP3908374A4 (en) COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF NEURODEGENERATIVE DISEASES
MA41010A (en) COMPOSITIONS INCLUDING BACTERIAL STRAINS
WO2013008102A3 (en) Methods and compositions for evaluating and/or treating chronic immune diseases
BR112014011127A2 (en) Methods for Treating, Diagnosing, and Monitoring Alzheimer's Disease
MA45125B1 (en) Anti-alpha-synuclein antibodies and their uses
EP3497452A4 (en) DIAGNOSIS, PREVENTION AND / OR TREATMENT OF AUTOIMMUNE DISEASES
BR112015028338A2 (en) methods of diagnosis or aid in the diagnosis and treatment of inflammatory bowel disease
ATE553778T1 (en) ANTIBODIES SPECIFIC TO HUMAN HEPCIDIN
EP3974450A3 (en) Biomarker
NZ729773A (en) Biomarkers for disease progression in melanoma
EA201792669A1 (en) IGFBP3 AND ITS APPLICATION
EP3602041A4 (en) METHODS FOR DIAGNOSING AND TREATING INFLAMMATORY INTESTINE DISEASE
MX2020006660A (en) BIOMARKERS OF IMMUNE TOLERANCE INDUCED BY METHOTREXATE.
MX2021009247A (en) Methods, systems, and kits for treating inflammatory disease targeting il18r1.
MX2022001087A (en) ERGOTHIONEINE, S-METHYL-ERGOTHIONEINE, AND USES THEREOF.
EP2920595A4 (en) METHOD FOR THE DIAGNOSIS OF CANCER AND ENZYME-RELATED IMMUNODOSE KIT (ELISA) FOR ITS APPLICATION
FR2963791B1 (en) METHOD OF DIAGNOSING NEURODEGENERATIVE DISEASES
MX2018000189A (en) Method for the diagnosis of farber's disease.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20180105

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

ST Notification of lapse

Effective date: 20230305